Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancer

There is limited data on the clinical and biological parameters that enable the prediction of the benefits derived from additional chemotherapy after disease progression compared with standard chemotherapy in patients with metastatic colorectal cancer (mCRC). The present study evaluated the role of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Kim, Ka-Rham, Yoon, Jung-Hwan, Shim, Hyun-Jeong, Hwang, Jun-Eul, Bae, Woo-Kyun, Chung, Ik-Joo, Kim, Hee-Nam, Shin, Min-Ho, Cho, Sang-Hee
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2017
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5530182/
https://ncbi.nlm.nih.gov/pubmed/28781687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6414
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi